Skip to main content

Research Oversight Committees

The Leukemia & Lymphoma Society's (LLS's) Research Oversight Committees are comprised of leading experts in their fields. Committee members are volunteers who give their time and talent to LLS and receive no compensation for their generous support.
 


Medical & Scientific Affairs Committee

Advises the Board of Directors on a range of issues, including recommending funding for research grant awards and periodically reviewing LLS’s medical affairs
 

Jonathan D. Licht, MD (Chair) 
UF Gainesville

Stephen Ansell, MD, PhD
Mayo Clinic, Rochester

Leif Bergsagel, MD
Mayo Clinic, Arizona

Ravi Bhatia, MD
The University of Alabama at Birmingham

Catherine Bollard, MD
Georgetown University

Lori Brown, PhD, MPH
FDA, Investigations Branch (formerly)

Renzo Canetta, MD +
Bristol-Myers Squibb (formerly)

Giulio Draetta, MD, PhD
The University of Texas MD Anderson Cancer Center

Christopher Flowers, MD +
The University of Texas MD Anderson Cancer Center

Janice Gabrilove, MD +
Mount Sinai

Irene Ghobrial, MD
Dana-Farber Cancer Institute

Larry Kwak, MD, PhD
City of Hope

Ruben Mesa, MD +
UT Health San Antonio

David Weinstock, MD
Dana-Farber Cancer Institute 


Therapy Acceleration Program Committee

Provides oversight and guidance on LLS’s Therapy Acceleration Program (TAP), a strategic initiative through which LLS partners directly with biotechnology companies and medical institutions to help accelerate the development of promising therapies
 

Casey Cunningham, MD (Chair) +
Santé Ventures

Giulio Draetta, MD, PhD
The University of Texas MD Anderson Cancer Center

Christoper Flowers, MD, MS, FASCO +
The University of Texas MD Anderson Cancer Center

Patrick Fortune, PhD, MBA
Partners Heathcare Systems

Laura Kaufman, PhD, DABT
Private Consultant

Ronald Levy, MD
Stanford University School of Medicine

Vern Norviel, Esq.
Wilson Sonsini Goodrich & Rosati

Jim Reddoch, PhD
Royalty Pharma

Robert Rosen, JD +
Grewhawke Capital Advisors

Steven Rosen, MD, FACP
City of Hope

Robert Spiegel, MD, FACP
Spiegel Consulting LLC

David Weinstock, MD
Dana-Farber Cancer Institute


+ National Board Member